BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Khashayar Hesamizadeh, Heidar Sharafi, Mohammad Saeid Rezaee-Zavareh, Bita Behnava, Seyed Moayed Alavian. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting AntiviralsHepatitis Monthly 2016; 16(4) doi: 10.5812/hepatmon.37089
2
Mohammad Pouryasin, Maryam Keshvari, Heidar Sharafi, Seyed Moayed Alavian, Bita Behnava, Seyed Ehsan Alavian, Ali Pouryasin. The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis CHepatitis Monthly 2016; 16(2) doi: 10.5812/hepatmon.35278
3
Heidar Sharafi, Mehri Nikbin, Seyed Hoda Alavian, Bita Behnava, Seyed Moayed Alavian. Efficacy and Safety of Generic Sofosbuvir/Ledipasvir Fixed-Dose Combination in Iranian Patients with Chronic Hepatitis C Virus InfectionHepatitis Monthly 2017; 17(6) doi: 10.5812/hepatmon.12216
4
Abdolvahab Alborzi, Tayebeh Hashempour, Javad Moayedi, Zahra Musavi, Gholamreza Pouladfar, Shahin Merat. Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patientsMedical Microbiology and Immunology 2017; 206(2): 165 doi: 10.1007/s00430-017-0497-y
5
Bita Behnava, Heidar Sharafi, Maryam Keshvari, Ali Pouryasin, Leila Mehrnoush, Shima Salimi, Pegah Karimi Elizee, Mehran Ghazimoghaddam, Seyed Moayed Alavian. The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis CHepatitis Monthly 2016; 16(1) doi: 10.5812/hepatmon.32703
6
Danesh Kadjbaf, Maryam Keshvari, Seyed Moayed Alavian, Ali Pouryasin, Bita Behnava, Shima Salimi, Leila Mehrnoush, Pegah Karimi Elizee, Heidar Sharafi. The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis CHepatitis Monthly 2016; 16(6) doi: 10.5812/hepatmon.37011
7
Mohammad Ehsan Bayatpoor, Mohammad Hossein Khosravi, Heidar Sharafi, Mohammad Saeid Rezaee-Zavareh, Bita Behnava, Seyed Moayed Alavian. Sofosbuvir and Ribavirin with or Without Pegylated-Interferon in Hepatitis C Virus Genotype-2 or -3 Infections: A Systematic Review and Meta-AnalysisArchives of Clinical Infectious Diseases 2019; (In Press) doi: 10.5812/archcid.79465
8
Fardin Dolatimehr, Hamidreza Karimi-Sari, Mohammad Saeid Rezaee-Zavareh, Seyed Moayed Alavian, Bita Behnava, Mohammad Gholami-Fesharaki, Heidar Sharafi. Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysisDARU Journal of Pharmaceutical Sciences 2017; 25(1) doi: 10.1186/s40199-017-0177-x
9
Saman Mohazzab-Torabi, Fardin Dolatimehr, Heidar Sharafi, Mahdi Safi-Abadi , Mohammad Saeid Rezaee-Zavareh, Ehsan Bayatpour, Hamidreza Karimi-Sari, Seyed Moayed Alavian. Treatment of HCV Infection with Direct-Acting Antiviral Agents in Patients with HIV/HCV Co-Infection: A Systematic ReviewHepatitis Monthly 2018; (In Press) doi: 10.5812/hepatmon.82971
10
Seyyed Mohammad Miri, Heidar Sharafi, Shima Salimi, Farah Bokharaei-Salim, Bita Behnava, Maryam Keshvari, Pegah Karimi Elizee, Hosein Keyvani, Seyed Moayed Alavian. Assessment of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells as a Predictor of Response to Pegylated-Interferon and Ribavirin: A Cohort StudyIranian Red Crescent Medical Journal 2017; 19(5) doi: 10.5812/ircmj.46578
11
Heidar Sharafi, Saeideh Maleki, Seyed Moayed Alavian. Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBankVirus Research 2019; 259: 54 doi: 10.1016/j.virusres.2018.10.014
12
Mohammad Pouryasin, Heidar Sharafi, Bita Behnava, Seyed Moayed Alavian, Maryam Keshvari, Ali Pouryasin. A Simple PCR-RFLP Method for Genotyping ofIFNL4rs368234815 Polymorphism in Patients With Chronic Hepatitis CLaboratory Medicine 2017; 48(1): 51 doi: 10.1093/labmed/lmw060
13
Humaira Naeemi, Rabia Aslam, Syed Mohsin Raza, Muhammad Aiman Shahzad, Shagufta Naz, Sobia Manzoor, Saba Khaliq. Distribution of IL28B and IL10 polymorphisms as genetic predictors of treatment response in Pakistani HCV genotype 3 patientsArchives of Virology 2018; 163(4): 997 doi: 10.1007/s00705-018-3711-3
14
Heidar Sharafi, Fereshte Amirahmadi, Seyed Moayed Alavian. Polymorphisms of IFNL3 and Response to Interferon-Based Treatments in Patients with Hepatitis D Infection: Systematic Review and Meta-AnalysisIranian Red Crescent Medical Journal 2017; 19(12) doi: 10.5812/ircmj.64392
15
Maryam Keshvari, Seyed Moayed Alavian, Bita Behnava, Ali Pouryasin, Johanna C. Craig, Heidar Sharafi. Impact ofIFNL4rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis CJournal of Clinical Laboratory Analysis 2017; 31(4): e22063 doi: 10.1002/jcla.22063
16
Heidar Sharafi, Seyed Moayed Alavian. Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?World Journal of Hepatology 2018; 10(9): 543-548 doi: 10.4254/wjh.v10.i9.543
17
Seyyed Mohammad Miri, Heidar Sharafi, Ali Pouryasin, Bita Behnava, Maryam Keshvari, Shima Salimi, Pegah Karimi Elizee, Seyed Moayed Alavian. The Role of Polymorphisms Near IFNL3 Gene as Predictors of Residual HCV RNA in Buffy Coat after Successful Antiviral TherapyHepatitis Monthly 2017; 17(4) doi: 10.5812/hepatmon.46539